Clik here to view.
Seniors missing out on important wellness exams
As health care reporters, we come across this truth time and again: insurance coverage doesn’t guarantee high quality medical care. The latest evidence comes from a survey of 1,028 seniors (age 65 and...
View ArticleGrowing challenges to safety, adequacy of drug supply #ahcj13
Essential, commonplace drugs are in short supply, including morphine, epinephrine and chemotherapy agents. Those shortages have led to a greater reliance on compounding pharmacies, such as the one...
View ArticleClik here to view.
Here’s why specialty pharmaceuticals need value-based insurance design
Image by Bill Brooks via flickr. This spring, Gilead Sciences Inc. introduced Solvaldi, a drug that could cure the liver virus that causes hepatitis C. The drawback, however, was the cost of $84,000 or...
View ArticleClik here to view.
Be cautious about superlatives in cancer drug reporting
Photo: Amy Dame via Flickr For much of modern medical history, the elusive holy grail of medical research has been a “cure for cancer.” Today, scientists have a better understanding of cancer, the...
View ArticleClik here to view.
More adults over 50 risk benzodiazepine misuse
Prescription rates of opioids and benzodiazepines are on the rise among the older adult population, according to two recent studies. And that is cause for concern, say researchers. In one study, Greg...
View ArticleClik here to view.
Updated Beers Criteria identifies risky drugs for seniors
A panel of experts in geriatric care has identified nearly 100 medications that should be avoided or used with caution among the older population in the latest update to the Beers Criteria for...
View ArticleClik here to view.
When covering drug-price reform, keep patients’ medication costs in perspective
The Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group for drug makers, produced the ad on the left that has been called misleading. The AARP produced the ad on the right...
View Article
